The serum tenascin C level is a marker of metabolic disorder-related inflammation affecting pancreatic cancer prognosis.
Obesity is a risk factor for pancreatic cancer development, partly due to the tissue environment of metabolic disorder-related inflammation. We aimed to detect a tissue environment marker triggered by obesity-related metabolic disorders related to pancreatic cancer...